Cargando…

Going for Gaps in Glaucoma

Detalles Bibliográficos
Autores principales:	Cvenkel, Barbara, Kolko, Miriam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487839/ https://www.ncbi.nlm.nih.gov/pubmed/37685561 http://dx.doi.org/10.3390/jcm12175494

Ejemplares similares

Novel Approaches to Optimize Treatment Strategies in Glaucoma
por: Kolko, Miriam, et al.
Publicado: (2021)

Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment
por: Cvenkel, Barbara, et al.
Publicado: (2020)

Devices and Treatments to Address Low Adherence in Glaucoma Patients: A Narrative Review
por: Cvenkel, Barbara, et al.
Publicado: (2022)

Exploring the Relationship between Anti-VEGF Therapy and Glaucoma: Implications for Management Strategies
por: Daka, Qëndresë, et al.
Publicado: (2023)

Enhanced Physiological Stress Response in Patients with Normal Tension Glaucoma during Hypoxia
por: Dalgaard, Line Marie, et al.
Publicado: (2021)

Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?
por: Mouhammad, Zaynab Ahmad, et al.
Publicado: (2022)

Monitoring for glaucoma progression with SAP, electroretinography (PERG and PhNR) and OCT
por: Cvenkel, Barbara, et al.
Publicado: (2021)

An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival
por: Freiberg, Josefine C., et al.
Publicado: (2022)

Inflammatory Molecules in Aqueous Humour and on Ocular Surface and Glaucoma Surgery Outcome
por: Cvenkel, Barbara, et al.
Publicado: (2010)

Relative Importance of Glaucoma-Referral Indicators in Retinal Images in a Diabetic Retinopathy Screening Programme in Slovenia: A Cross-Sectional Study
por: Podnar, Barbara, et al.
Publicado: (2023)

Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma
por: Cvenkel, Barbara, et al.
Publicado: (2015)

Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype
por: Atanasovska Velkovska, Makedonka, et al.
Publicado: (2021)

Present and New Treatment Strategies in the Management of Glaucoma
por: Kolko, M.
Publicado: (2015)

A Scoping Review of Quality of Life Questionnaires in Glaucoma Patients
por: Gazzard, Gus, et al.
Publicado: (2021)

Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development
por: Storgaard, Line, et al.
Publicado: (2021)

Balloon aortic valvuloplasty in high-risk patients: when the going gets tough, the tough get going
por: Dall’Ara, Gianni, et al.
Publicado: (2022)

Danish Nationwide Data Reveal a Link between Diabetes Mellitus, Diabetic Retinopathy, and Glaucoma
por: Horwitz, Anna, et al.
Publicado: (2016)

Where is genomics going next?
por: Cheifet, Barbara
Publicado: (2019)

The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study
por: Kolko, Miriam, et al.
Publicado: (2015)

Rheumatoid vasculitis: going, going, but not yet gone
por: Pisetsky, David S
Publicado: (2015)

Monochromatic Pupillometry in Unilateral Glaucoma Discloses no Adaptive Changes Subserved by the ipRGCs
por: Nissen, Claus, et al.
Publicado: (2014)

Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
por: García-Bermúdez, Mariana Y., et al.
Publicado: (2021)

Artificial Intelligence and Glaucoma: Going Back to Basics
por: AlRyalat, Saif Aldeen, et al.
Publicado: (2023)

Go with the flow…..
por: Quax, Paul H A, et al.
Publicado: (2022)

Going on Eighteen
Publicado: (1902)

“If you want to go fast, go alone. If you want to go far, go together”: A call for a Nordic engagement in the development of family medicine in Africa
por: Kallestrup, Per, et al.
Publicado: (2013)

Update on glaucoma
por: Wolvaardt, Elmien, et al.
Publicado: (2021)

What Is Going on with Childhood?
por: Cerniglia, Luca
Publicado: (2023)

Going with Your Gut
por: Dhaliwal, Gurpreet
Publicado: (2010)

Where are we going?
por: Pawl, Ronald P.
Publicado: (2010)

Here We Go!
por: Grady, Melissa D.
Publicado: (2022)

It’s time to go …
por: Solymosi, László
Publicado: (2022)

Considering comorbidity in managing rheumatic diseases: going where trials cannot go
por: Aletaha, Daniel, et al.
Publicado: (2011)

COVID-19 and ethics: We learn as we go. But where are we going?
por: Le Dorze, Matthieu, et al.
Publicado: (2021)

The Impact of COVID-19 on Continuing Professional Development: Go Green and Go Home?
por: Windrim, Rory C., et al.
Publicado: (2022)

The Gaps
Publicado: (1962)

Transforming glaucoma care pathways: current glaucoma accreditation in UK optometry
por: Harper, Robert A., et al.
Publicado: (2021)

Minimally invasive glaucoma surgery devices in glaucoma: A time for reflection
por: Sarran, Rebecca D., et al.
Publicado: (2020)

The BENEFIT Trial: Where Do We Go from Here?
por: Pecoul, Bernard, et al.
Publicado: (2016)

Advances in Amylases—What’s Going on?
por: Janeček, Štefan
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m2h1tt0vh2kj627b3nfmk96ja8